ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,640Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 1006

$808K Total Retail Price of All Prescriptions

Rank: 78 out of 1006

405 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 405 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 7,310 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 409 349 1 4
FUROSEMIDE 356 306 2 6
LEVOTHYROXINE SODIUM 280 244 3 2
AZITHROMYCIN 272 195 4 39
OXYCODONE HCL 263 67 S2 5 54
METOPROLOL TARTRATE 245 232 6 7
ATENOLOL 227 210 7 13
ZOLPIDEM TARTRATE 213 119 8 14
ATORVASTATIN CALCIUM 206 180 9 5
LISINOPRIL 190 176 10 3
OMEPRAZOLE 170 138 11 9
METFORMIN HCL 157 122 12 10
NEXIUM 139 103 13 28
HYDROCODONE-ACETAMINOPHEN 134 86 S3 14 25
OXYCONTIN 117 27 S2 15 98
CRESTOR 104 73 16 18
CEFUROXIME 103 61 17 170
LOSARTAN POTASSIUM 93 88 18 22
METOPROLOL SUCCINATE 92 85 19 12
HYDROCHLOROTHIAZIDE 90 81 20 11
POTASSIUM CHLORIDE 89 76 21 30
BENICAR 88 88 22 78
SIMVASTATIN 87 87 23 1
SYNTHROID 83 81 24 42
GLYBURIDE 81 75 R 25 65
SPIRONOLACTONE 80 43 26 71
TRAZODONE HCL 79 72 27 21
TAMSULOSIN HCL 78 75 28 23
CITALOPRAM HBR 78 66 28 24
ESCITALOPRAM OXALATE 73 73 30 27
LEVOFLOXACIN 69 33 31 96
MORPHINE SULFATE ER 68 11 S2 32 142
PREDNISONE 66 47 33 33
MOMETASONE FUROATE 65 46 34 261
PANTOPRAZOLE SODIUM 65 65 34 32
DEXILANT 63 37 36 142
CIPROFLOXACIN HCL 62 57 37 75
SERTRALINE HCL 60 44 38 19
ONGLYZA 60 47 38 230
PRAVASTATIN SODIUM 60 48 38 15
ALENDRONATE SODIUM 58 58 41 29
ISOSORBIDE MONONITRATE ER 56 48 42 59
GLIMEPIRIDE 53 42 43 50
LIPITOR 53 43 43 47
PLAVIX 52 46 45 61
DIOVAN 52 52 45 16
CLOPIDOGREL 51 40 47 46
CYMBALTA 51 0 47 41
PROAIR HFA 51 0 47 64
WARFARIN SODIUM 50 50 50 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.